Pharmacor takes aim at Novartis patents for MS drug Gilenya

Ben Mee 2021-05-05 11:31 am By Cat Fredenburgh | Melbourne

Please login to bookmark

Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant’s patents for its blockbuster MS drug Gilenya.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au